Main competitors
Dividend Yield (Y) Dividend Yield (Y+1) P/E (Y) Price to Book (Y) EV / Sales (Y) EV / EBITDA (Y) EV / EBIT (Y) Capi.($)
1.74%1.81%22.53x1.89x3.11x11.07x18.15x 67.23B
2.9%3%51.5x5.86x4.81x19.55x27.16x 285B
2.81%3%15.9x1.37x1.99x6.83x8.16x 7.99B
-.--%-.--%22.75x6.34x6.83x18.66x19.48x 4.67B
0.7%0.71%43.92x2.62x2.49x30.32x44.92x 3.9B
-.--%-.--%100.57x - - - - 2.53B
4.1%3.96%12.46x0.83x1.11x28.01x-76.3x 1.01B
-.--%-.--%-7.64x12.77x211.78x-6.82x-5.34x 999M
Average 1.53% 1.56% 32.75x 4.53x 33.16x 15.37x 5.18x 46.68B
Weighted average by Cap. 2.6% 2.7% 45.15x 5.02x 4.99x 17.79x 24.84x
Specialty & Advanced Pharmaceuticals
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!